385 related articles for article (PubMed ID: 35246149)
1. Facile synthesis of near-infrared responsive on-demand oxygen releasing nanoplatform for precise MRI-guided theranostics of hypoxia-induced tumor chemoresistance and metastasis in triple negative breast cancer.
Zhang D; You Y; Xu Y; Cheng Q; Xiao Z; Chen T; Shi C; Luo L
J Nanobiotechnology; 2022 Mar; 20(1):104. PubMed ID: 35246149
[TBL] [Abstract][Full Text] [Related]
2. Tumor Cell Targeting and Responsive Nanoplatform for Multimodal-Imaging Guided Chemodynamic/Photodynamic/Photothermal Therapy toward Triple Negative Breast Cancer.
Li L; Li J; Hu R; Zhang X; Ding L; Ren G; Liu W; Wang H; Wang B; Zhang C; Diao H
ACS Appl Mater Interfaces; 2023 Jun; 15(23):27706-27718. PubMed ID: 37261936
[TBL] [Abstract][Full Text] [Related]
3. An all-in-one nanoplatform with near-infrared light promoted on-demand oxygen release and deep intratumoral penetration for synergistic photothermal/photodynamic therapy.
Liu X; Li R; Zhou Y; Lv W; Liu S; Zhao Q; Huang W
J Colloid Interface Sci; 2022 Feb; 608(Pt 2):1543-1552. PubMed ID: 34742072
[TBL] [Abstract][Full Text] [Related]
4. NIR-laser-triggered gadolinium-doped carbon dots for magnetic resonance imaging, drug delivery and combined photothermal chemotherapy for triple negative breast cancer.
Jiang Q; Liu L; Li Q; Cao Y; Chen D; Du Q; Yang X; Huang D; Pei R; Chen X; Huang G
J Nanobiotechnology; 2021 Mar; 19(1):64. PubMed ID: 33653352
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-responsive covalent organic framework by single NIR laser-triggered for multimodal synergistic therapy of triple-negative breast cancer.
Han Z; Qian Y; Gao X; Yang D; Cai Y; Chen Y; Jin J; Yang Z
Colloids Surf B Biointerfaces; 2023 Feb; 222():113094. PubMed ID: 36535221
[TBL] [Abstract][Full Text] [Related]
6. Photoacoustic imaging-guided triple-responsive nanoparticles with tumor hypoxia relief for improving chemotherapy/ photothermal/photodynamic synergistic therapy against breast cancer.
Yu C; Kong L; Tian J; Zhang Y; Jia X; Dang W; Xing B; Zhang Q; Pang X; Hu Z; Jia B; He J; Zhang ZM; Liu Z
Biomed Pharmacother; 2023 Aug; 164():114928. PubMed ID: 37263164
[TBL] [Abstract][Full Text] [Related]
7. Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect.
Dong Y; Dong S; Wang Z; Feng L; Sun Q; Chen G; He F; Liu S; Li W; Yang P
ACS Appl Mater Interfaces; 2020 Nov; 12(47):52479-52491. PubMed ID: 33196186
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Responsive Multifunctional Nanoplatform Based on Peptide Self-Assembly for Highly Efficient Combined Cancer Therapy by Alleviating Hypoxia and Improving the Immunosuppressive Microenvironment.
Wu J; Liu Y; Cao M; Zheng N; Ma H; Ye X; Yang N; Liu Z; Liao W; Sun L
ACS Appl Mater Interfaces; 2023 Feb; 15(4):5667-5678. PubMed ID: 36651290
[TBL] [Abstract][Full Text] [Related]
10. Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer.
Fang H; Gai Y; Wang S; Liu Q; Zhang X; Ye M; Tan J; Long Y; Wang K; Zhang Y; Lan X
J Nanobiotechnology; 2021 Mar; 19(1):81. PubMed ID: 33743740
[TBL] [Abstract][Full Text] [Related]
11. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
12. Gold Cube-in-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal Imaging.
Zhang X; Xi Z; Machuki JO; Luo J; Yang D; Li J; Cai W; Yang Y; Zhang L; Tian J; Guo K; Yu Y; Gao F
ACS Nano; 2019 May; 13(5):5306-5325. PubMed ID: 31018094
[TBL] [Abstract][Full Text] [Related]
13. All-in-one approaches for triple-negative breast cancer therapy: metal-phenolic nanoplatform for MR imaging-guided combinational therapy.
Xie Q; Li S; Feng X; Shi J; Li Y; Yuan G; Yang C; Shen Y; Kong L; Zhang Z
J Nanobiotechnology; 2022 May; 20(1):226. PubMed ID: 35549947
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment responsive hollow mesoporous Co
Huang J; Huang Y; Xue Z; Zeng S
Biomaterials; 2020 Dec; 262():120346. PubMed ID: 32927232
[TBL] [Abstract][Full Text] [Related]
15. The strategy of precise targeting and
Wu M; Chen T; Wang L; Akakuru OU; Ma X; Xu J; Hu J; Chen J; Fang Q; Wu A; Li Q
Nanoscale; 2022 Jun; 14(23):8349-8361. PubMed ID: 35635070
[TBL] [Abstract][Full Text] [Related]
16. NIR diagnostic imaging of triple-negative breast cancer and its lymph node metastasis for high-efficiency hypoxia-activated multimodal therapy.
Pan Y; Liu L; He Y; Ye L; Zhao X; Hu Z; Mou X; Cai Y
J Nanobiotechnology; 2023 Sep; 21(1):312. PubMed ID: 37660121
[TBL] [Abstract][Full Text] [Related]
17. NIR-II Excitation Phototheranostic Nanomedicine for Fluorescence/Photoacoustic Tumor Imaging and Targeted Photothermal-Photonic Thermodynamic Therapy.
Dai Y; Zhao H; He K; Du W; Kong Y; Wang Z; Li M; Shen Q; Sun P; Fan Q
Small; 2021 Oct; 17(42):e2102527. PubMed ID: 34528387
[TBL] [Abstract][Full Text] [Related]
18. Multicomponent-assembled nanodiamond hybrids for targeted and imaging guided triple-negative breast cancer therapy
Cui X; Deng X; Liang Z; Lu J; Shao L; Wang X; Jia F; Pan Z; Hu Q; Xiao X; Wu Y; Sheng W
Biomater Sci; 2021 May; 9(10):3838-3850. PubMed ID: 33885068
[TBL] [Abstract][Full Text] [Related]
19. Near-infrared laser-induced phase-shifted nanoparticles for US/MRI-guided therapy for breast cancer.
Shi M; Zuo F; Tao Y; Liu Y; Lu J; Zheng S; Lu J; Hou P; Li J; Xu K
Colloids Surf B Biointerfaces; 2020 Dec; 196():111278. PubMed ID: 32835889
[TBL] [Abstract][Full Text] [Related]
20. Near Infrared-Triggered Theranostic Nanoplatform with Controlled Release of HSP90 Inhibitor for Synergistic Mild Photothermal and Enhanced Nanocatalytic Therapy with Hypoxia Relief.
Tian B; Wang C; Du Y; Dong S; Feng L; Liu B; Liu S; Ding H; Gai S; He F; Yang P
Small; 2022 Jul; 18(28):e2200786. PubMed ID: 35661402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
